It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Decide which is better for your needs: credit card points or cash back. Evaluate the benefits to optimize your rewards strategy.
27,103 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Booking Holdings beat revenue estimates for Q4 2025, yet investors dumped shares as guidance for 2026 signaled slower...
A senior macro investor warns that the global order is entering a perilous stage of the Big Cycle, likely to test mar...
eBay rejected GameStop's unsolicited $56 billion takeover offer, labeling it neither credible attractive. The decisio...
A surge in tariff refunds could inject liquidity into the U.S. financial system, potentially lifting Bitcoin and othe...
HIVE Blockchain posted a standout revenue gain for the year, even as its bitcoin stash declined to 150 BTC, highlight...
CFO compensation rose about 8% in 2025 as long-term incentives surged last year—and long-term incentives now dominate...
A former OpenAI safety researcher urges households to stress-test AI futures and plan accordingly, highlighting a fiv...
When life tests a family, money becomes a shared tool. This article draws on the idea behind john stamos says family ...
Pershing Square disclosed a single new equity position this quarter: Meta Platforms. The bet is large enough to tilt ...
AI adoption is boosting demand for security platforms, pushing traders toward these cybersecurity stocks wall as dura...
Retirees who start Social Security early and continue working may see withheld benefits restored later. The earnings ...